|Bid||8.63 x 2200|
|Ask||8.68 x 1200|
|Day's range||8.25 - 8.91|
|52-week range||6.31 - 17.45|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||12.67|
Shareholder rights law firm Robbins LLP is investigating Clover Health Investments, Corp. (NASDAQ: CLOV) on behalf of shareholders to determine whether certain Clover officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company. Clover Health provides medical insurance services.
Chamath Palihapitiya By Jarrett Banks and John Jannarone Short interest in Chamath Palihapitiya-backed Clover Health Investments Corp. (Nasdaq: CLOV) is at 40.6 million shares, data compiled by financial analytics firm S3 Partners shows. This reflects approximately 37% of the float according to an updated estimate from FactSet, which changed over the weekend after IPO Edge covered the […]
Clover appoints new board member, former CMS official, to help grow company.